Cargando…

Efficacy of Apatinib plus S-1 Therapy in the Treatment of Advanced Gastric Cancer Patients and the Effect on the Levels of Tumor Markers and Th1 and Th2-Like Cytokines

OBJECTIVE: To assess the efficacy of apatinib plus S-1 therapy in the treatment of advanced gastric cancer patients and the effect on the levels of tumor markers and Th1 and Th2-like cytokines. METHODS: From October 2019 to December 2020, 100 patients with advanced gastric cancer assessed for eligib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Jishu, Ni, Xuejiao, Ji, Jinfeng, Wei, Guohua, Shi, Lei, Xu, Chunming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068304/ https://www.ncbi.nlm.nih.gov/pubmed/35529932 http://dx.doi.org/10.1155/2022/8060026

Ejemplares similares

Efficacy of the Low Dose Apatinib plus Chemotherapy on Advanced Gastric Carcinoma
por: Gao, Shen, et al.
Publicado: (2022)

Neoadjuvant PD-1 Inhibitor Plus Apatinib and Chemotherapy Versus Apatinib Plus Chemotherapy in Treating Patients With Locally Advanced Gastric Cancer: A Prospective, Cohort Study
por: Wang, Chunjing, et al.
Publicado: (2023)

Safety of apatinib plus S-1 for advanced solid tumor as palliative treatment
por: Chen, Siying, et al.
Publicado: (2021)

Apatinib combined with S-1 as second-line therapy in advanced gastric cancer
por: Qiu, Zhi-Yuan, et al.
Publicado: (2021)

Treatment Response, Survival Benefit and Safety Profile of PD-1 Inhibitor Plus Apatinib Versus Apatinib Monotherapy in Advanced Colorectal Cancer Patients
por: Pan, Dengdeng, et al.
Publicado: (2022)

Feasibility and Tolerance of Apatinib plus PD-1 Inhibitors for Previously Treated Advanced Gastric Cancer: A Real-World Exploratory Study
por: Li, Li-Hua, et al.
Publicado: (2022)

Neoadjuvant apatinib plus tegafur/gimeracil/oteracil potassium (S‑1)/oxaliplatin chemotherapy vs. chemotherapy alone in patients with locally advanced gastric carcinoma
por: Wang, Zhenfeng, et al.
Publicado: (2022)

Neoadjuvant apatinib plus S-1 in locally advanced pulmonary adenocarcinoma: A case report and review of the literature
por: Zhang, Chu, et al.
Publicado: (2020)

Th1, Th2, and Th17 cells and their corresponding cytokines are associated with anxiety, depression, and cognitive impairment in elderly gastric cancer patients
por: Zhou, Yanxia, et al.
Publicado: (2022)

Th1, Th2, and Th17 Cytokine Involvement in Thyroid Associated Ophthalmopathy
por: Shen, Jie, et al.
Publicado: (2015)

Perioperative Safety and Effectiveness of Neoadjuvant Therapy with Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel Plus Apatinib in Locally Advanced Gastric Cancer
por: Zhang, Yonglei, et al.
Publicado: (2021)

Effectiveness and Safety of Apatinib Plus Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer: A Nonrandomized Controlled Trial
por: Lin, Jian-Xian, et al.
Publicado: (2021)

Th1/Th2 Cells and Associated Cytokines in Acute Hepatitis E and Related Acute Liver Failure
por: Wu, Jian, et al.
Publicado: (2020)

Modulation of Th1/Th2 Cytokine Balance by Quercetin In Vitro
por: Tanaka, Yoshihito, et al.
Publicado: (2020)

The Efficacy of Transarterial Chemoembolization plus Apatinib or Sorafenib in the Treatment of Advanced Hepatocellular Carcinoma
por: Chen, Lei, et al.
Publicado: (2021)

Apatinib in Advanced Gastric Cancer: A Doubtful Step Forward
por: Fornaro, Lorenzo, et al.
Publicado: (2016)

Multiple Cytokine Analysis of Th1/Th2/Th9/Th17/Th22/Treg Cytokine Pathway for Individual Immune Profile Assessment in Patients with Psoriasis
por: Michalak-Stoma, Anna, et al.
Publicado: (2022)

Apatinib combined with PD-1 antibody for third-line or later treatment of advanced gastric cancer
por: Cui, Qingli, et al.
Publicado: (2022)

Drug-related adverse events potentially predict the efficacy of apatinib on advanced hepatocellular carcinoma
por: Gu, Xiaoying, et al.
Publicado: (2022)

Efficacy of Conversion Surgery Following Apatinib Plus Paclitaxel/S1 for Advanced Gastric Cancer With Unresectable Factors: A Multicenter, Single-Arm, Phase II Trial
por: Xu, Zhiyuan, et al.
Publicado: (2021)

Protocol for a randomized controlled trial of perioperative S-1 plus oxaliplatin combined with apatinib and camrelizumab in patients with resectable, locally advanced gastric or gastroesophageal junction adenocarcinoma
por: Zheng, Yanan, et al.
Publicado: (2020)

The relation of cytokines TH1, TH2 and TH17 in childhood-onset systemic lupus erythematosus
por: Peliçari, Karina, et al.
Publicado: (2014)

Expression and Clinical Significance of Th1/Th2/Th17 Cytokines and Lymphocyte Subsets in PCNSL
por: Bian, Haiyan, et al.
Publicado: (2022)

Age-related differentiations of Th1/Th2 cytokines in newborn infants.
por: Protonotariou, Efthimia, et al.
Publicado: (2004)

Effects of Acupuncture on Th1, Th2 Cytokines in Rats of Implantation Failure
por: Gui, Juan, et al.
Publicado: (2012)

Academic stress-induced changes in Th1- and Th2-cytokine response
por: Assaf, Areej M., et al.
Publicado: (2017)

The correlations between Th1 and Th2 cytokines in human alveolar echinococcosis
por: Ma, Xiao, et al.
Publicado: (2020)

Th1/Th2 cytokines in Type 1 diabetes: Relation to duration of disease and gender
por: Vaseghi, Hajar, et al.
Publicado: (2016)

Apatinib Plus Chemotherapy Shows Clinical Activity in Advanced NSCLC: A Retrospective Study
por: Tang, Jing, et al.
Publicado: (2019)

The increased but non-predominant expression of Th17- and Th1-specific cytokines in Hashimoto's thyroiditis but not in Graves' disease
por: Qin, Qiu, et al.
Publicado: (2012)

Efficacy of the low dose apatinib plus deep hyperthermia as third-line or later treatment in HER-2 negative advanced gastric cancer
por: Han, Guohu, et al.
Publicado: (2023)

Cocaine Use Disorder Is Associated With Changes in Th1/Th2/Th17 Cytokines and Lymphocytes Subsets
por: Zaparte, Aline, et al.
Publicado: (2019)

Th1/Th2/Th17 Cytokine Profile among Different Stages of COVID-19 Infection
por: Gupta, Gaurav, et al.
Publicado: (2022)

The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications
por: Waśkiel-Burnat, Anna, et al.
Publicado: (2021)

PD-1 inhibitor combined with apatinib for advanced gastric or esophagogastric junction cancer: a retrospective study
por: Wei, Qing, et al.
Publicado: (2020)

Concurrent apatinib and docetaxel vs apatinib monotherapy as third- or subsequent-line therapy for advanced gastric adenocarcinoma: a retrospective study
por: Lin, Haimin, et al.
Publicado: (2019)

Simultaneous analysis of T helper subsets (Th1, Th2, Th9, Th17, Th22, Tfh, Tr1 and Tregs) markers expression in periapical lesions reveals multiple cytokine clusters accountable for lesions activity and inactivity status
por: ARAUJO-PIRES, Ana Claudia, et al.
Publicado: (2014)

Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Apatinib Compared with Conventional Transarterial Chemoembolization Plus Apatinib in the Treatment of Unresectable Hepatocellular Carcinoma
por: Zhang, Weihua, et al.
Publicado: (2021)

Ontogenic Development of Th1 and Th2 Cytokine Capabilities in Random Bred Mice
por: Fagoaga, Omar R., et al.
Publicado: (2002)

Circulating Th1 and Th2 cytokines in patients with hepatitis C virus infection.
por: Fan, X G, et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_bjp5asnmou45pe9r5ne1929as6